Adaptive Biotechnologies Corporation (ADPT) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$14.21
Day's range
$15.17

Adaptive Biotechnologies Corp Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
VIKING GLOBAL INVESTORS LP 05/15/2026 29.99 M $416.31 M   0.00% 19.59%
BLACKROCK, INC. 05/13/2026 13.30 M $184.65 M   -0.23% 8.69%
05/15/2026 6.09 M $84.59 M   100.00% 3.98%
WESTFIELD CAPITAL MANAGEMENT CO LP 05/11/2026 5.44 M $75.46 M   33.89% 3.55%
05/08/2026 4.49 M $62.34 M   100.00% 2.93%
INVESCO LTD. 05/12/2026 4.45 M $61.77 M   43.20% 2.91%
WELLINGTON MANAGEMENT GROUP LLP 05/15/2026 3.86 M $53.54 M   78.15% 2.52%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 3.64 M $50.48 M   3.54% 2.37%
LORD, ABBETT & CO. LLC 05/14/2026 3.54 M $49.08 M   14.78% 2.31%
GOLDMAN SACHS GROUP INC 05/15/2026 3.24 M $45.00 M   11.71% 2.12%
STATE STREET CORP 05/15/2026 3.23 M $44.79 M   1.43% 2.11%
AMERIPRISE FINANCIAL INC 05/15/2026 3.02 M $41.88 M   16.46% 1.97%
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. 05/14/2026 2.69 M $37.31 M   100.00% 1.76%
ARK INVESTMENT MANAGEMENT LLC 05/12/2026 2.09 M $29.05 M   -2.15% 1.37%
FRED ALGER MANAGEMENT, LLC 05/15/2026 2.06 M $28.64 M   -8.12% 1.35%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 05/14/2026 2.00 M $27.69 M   -17.62% 1.30%
D. E. SHAW & CO., INC. 05/15/2026 1.97 M $27.28 M   3.31% 1.28%
MACQUARIE MANAGEMENT HOLDINGS, INC. 05/15/2026 1.88 M $26.11 M   -3.05% 1.23%
DRIEHAUS CAPITAL MANAGEMENT LLC 05/15/2026 1.75 M $24.30 M   -36.58% 1.14%
ARISTOTLE ATLANTIC PARTNERS, LLC 05/15/2026 1.71 M $23.80 M   -6.95% 1.12%
PRINCIPAL FINANCIAL GROUP INC 05/04/2026 1.70 M $23.66 M   9.82% 1.11%
SUMITOMO MITSUI TRUST HOLDINGS, INC. 04/30/2026 1.60 M $22.14 M   -18.10% 1.04%
NIKKO ASSET MANAGEMENT AMERICAS, INC. 05/07/2026 1.60 M $22.14 M   -18.10% 1.04%
PRICE T ROWE ASSOCIATES INC /MD/ 05/15/2026 1.57 M $21.74 M   -64.30% 1.02%
NORTHERN TRUST CORP 05/14/2026 1.39 M $19.33 M   18.72% 0.91%
DIVISADERO STREET CAPITAL MANAGEMENT, LP 05/15/2026 1.32 M $18.30 M   264.93% 0.86%
NUVEEN, LLC 04/30/2026 1.30 M $18.10 M   65.79% 0.85%
CAPRICORN FUND MANAGERS LTD 04/24/2026 1.29 M $17.93 M   100.00% 0.84%
BANK OF AMERICA CORP /DE/ 05/18/2026 1.23 M $17.04 M   52.30% 0.80%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 1.15 M $15.90 M   -2.37% 0.75%
MILLENNIUM MANAGEMENT LLC 05/15/2026 1.08 M $15.01 M   5,790.76% 0.71%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 05/14/2026 1.07 M $14.88 M   16.24% 0.70%
ABRDN PLC 04/29/2026 1.07 M $14.86 M   2.30% 0.70%
POINT72 ASSET MANAGEMENT, L.P. 05/15/2026 1.02 M $14.18 M   403.17% 0.67%
BLUE WATER LIFE SCIENCE ADVISORS, LP 05/14/2026 1.01 M $14.02 M   -42.77% 0.66%
MORGAN STANLEY 05/15/2026 967.12 K $13.42 M   -15.84% 0.63%
KENNEDY CAPITAL MANAGEMENT LLC 05/13/2026 931.52 K $12.93 M   3.48% 0.61%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 05/15/2026 919.28 K $12.76 M   29,288.68% 0.60%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 870.96 K $12.09 M   100.00% 0.57%
OBERWEIS ASSET MANAGEMENT INC/ 05/15/2026 806.95 K $11.20 M   8.39% 0.53%
TUDOR INVESTMENT CORP ET AL 05/15/2026 786.28 K $10.91 M   41.92% 0.51%
DEUTSCHE BANK AG\ 05/06/2026 785.78 K $10.91 M   -54.70% 0.51%
JENNISON ASSOCIATES LLC 05/06/2026 753.07 K $10.45 M   -71.84% 0.49%
CATALIO CAPITAL MANAGEMENT, LP 05/15/2026 722.78 K $10.03 M   -11.98% 0.47%
RHENMAN & PARTNERS ASSET MANAGEMENT AB 05/14/2026 720.00 K $9.99 M   19.01% 0.47%
JANE STREET GROUP, LLC 05/12/2026 682.18 K $9.47 M   100.00% 0.45%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 05/11/2026 649.63 K $9.02 M   9.86% 0.42%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2026 639.38 K $8.87 M   -30.06% 0.42%
HILLSDALE INVESTMENT MANAGEMENT INC. 05/04/2026 625.22 K $8.68 M   1.34% 0.41%
TREXQUANT INVESTMENT LP 05/15/2026 571.58 K $7.93 M   116.54% 0.37%

Adaptive Biotechnologies Corp institutional Ownership - FAQ's

During the previous two years, 374 institutional investors and hedge funds held shares of Adaptive Biotechnologies Corp. The most heavily invested institutionals were:

VIKING GLOBAL INVESTORS LP: 29.99 M

BlackRock, Inc.: 13.3 M

WESTFIELD CAPITAL MANAGEMENT CO LP: 5.44 M

Invesco Ltd.: 4.45 M

WELLINGTON MANAGEMENT GROUP LLP: 3.86 M

GEODE CAPITAL MANAGEMENT, LLC: 3.64 M

99.17% of Adaptive Biotechnologies Corp stock is owned by institutional investors.

Institutional investors have bought a total of 169.87 M shares in the last 24 months. This purchase volume represents approximately $2.54 B in transactions.